Ally Olotu, MD, DPhil

Ally Olotu is a Senior Scientist and Director of Science at the Ifakara Health Institute in Tanzania. With over 14 years of experience in infectious disease epidemiology and immunology, he leads research focused on malaria vaccine development and implementation. Olotu has conducted pivotal studies on the RTS,S malaria vaccine, assessing its safety, immunogenicity, and efficacy in endemic populations. Currently, he is leading Phase I and III trials of second-generation malaria vaccine candidates and establishing capacity for controlled human malaria infection studies in endemic populations. As a Senior Fellow of the European and Developing Countries Clinical Trials Partnership (EDCTP), he is also advancing research on transmission-blocking malaria vaccines and evaluating the impact of detecting and treating low-density malaria infections in young children.